Dr. Haibo Xu is a professor in the department of pharmacology, school of pharmacy, at the Chengdu University of Traditional Chinese Medicine (TCM), Sichuan, China. He got a bachelor's degree in medicine at the Southwest Medical University in China in 1997, a master's degree in pharmacology at the Guangzhou University of TCM in 2000, and a PhD in molecular pharmacology at the Guangzhou University of TCM in 2003, followed by his 6-month lectureship in the institute of gastroenterology, Guangzhou University of TCM, Guangdong, China. From March 2004 to February 2007, Dr. Xu was a postdoctoral research fellow in cancer biology in the department of surgery, centre for cancer research and cell biology, Queen’s University Belfast, UK, followed by another over 3-year research on hypertension in the school of physiology and pharmacology in the University of Bristol, UK. Dr. Xu has been holding several research grants as a principle investigator in China, with 40 published papers and 6 oral presentations in international conferences. He was awarded the European Investigators’ Travel Grant by the 19th European meeting on hypertension in Milan, organized by the European Society of Hypertension in 2009. He also received 4 travel grants from British Heart Foundation, Physiological Society of UK and the Cancer Recognised Research Group of Northen Ireland.
Dr. Haibo Xu’s research focus on the pathogenesis of gastrointestinal cancer, hepatitis, hypertension, and the therapeutic intervention in these diseases with traditional Chinese medicine, along with the delineation of the underlying mechanisms for Chinese herbal effects.